Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Return on Sales (2018 - 2025)

Historic Return on Sales for AVITA Medical (RCEL) over the last 8 years, with Q4 2025 value amounting to 0.13%.

  • AVITA Medical's Return on Sales rose 10900.0% to 0.13% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.33%, marking a year-over-year increase of 7800.0%. This contributed to the annual value of 0.53% for FY2025, which is 110400.0% up from last year.
  • Per AVITA Medical's latest filing, its Return on Sales stood at 0.13% for Q4 2025, which was up 10900.0% from 0.77% recorded in Q3 2025.
  • In the past 5 years, AVITA Medical's Return on Sales ranged from a high of 0.13% in Q4 2025 and a low of 1.68% during Q1 2024
  • Moreover, its 5-year median value for Return on Sales was 0.76% (2022), whereas its average is 0.82%.
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 32000bps in 2021, then plummeted by -8100bps in 2024.
  • AVITA Medical's Return on Sales (Quarter) stood at 0.64% in 2021, then grew by 9bps to 0.58% in 2022, then plummeted by -100bps to 1.16% in 2023, then dropped by -5bps to 1.22% in 2024, then skyrocketed by 90bps to 0.13% in 2025.
  • Its Return on Sales was 0.13% in Q4 2025, compared to 0.77% in Q3 2025 and 0.54% in Q2 2025.